> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-26/
- Published: 2020-11-29T12:00:00.000Z
- Updated: 2026-09-14T16:38:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146503

[**Info Collection on Dietary Supplement GMPs**](https://www.fdaweb.com/info-collection-on-dietary-supplement-gmps/)  
Federal Register notice: FDA sends to OMB an information collection revision entitled “Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements — 21 CFR Part 111.” 11/25/2020

[**Info Collection on Special Protocols**](https://www.fdaweb.com/info-collection-on-special-protocols/)  
Federal Register notice: FDA submits to OMB an information collection revision for “Special Protocol Assessments.” 11/25/2020

[**FDA Reclassifying Some Hepatitis Tests**](https://www.fdaweb.com/fda-reclassifying-some-hepatitis-tests/)  
Federal Register notice: FDA proposes to reclassify certain hepatitis C virus antibody assay devices from Class 3 to Class 2 (general controls and special controls). 11/24/2020

[**Regs Amended on 510(k)-Exempt Devices**](https://www.fdaweb.com/regs-amended-on-510-k-exempt-devices/)  
Federal Register notice: FDA amends certain medical device regulations to accurately reflect the devices exempted from premarket notification (510(k)). 11/24/2020

[**CDRH Organization Structures Amended in Regs**](https://www.fdaweb.com/cdrh-organization-structures-amended-in-regs/)  
Federal Register notice: FDA amends its medical device regulations to reflect changes to CDRH’s organizational structure, including the reorganization of its offices. 11/23/2020